Ligand Pharmaceuticals
LGND
#4135
Rank
ยฃ1.75 B
Marketcap
ยฃ92.78
Share price
4.47%
Change (1 day)
99.03%
Change (1 year)

Revenue for Ligand Pharmaceuticals (LGND)

Revenue in 2024 (TTM): ยฃ0.10 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ0.10 Billion. In 2023 the company made a revenue of ยฃ0.10 Billion a decrease over the revenue in the year 2022 that were of ยฃ0.14 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ligand Pharmaceuticals from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.10 B3.19%
2023 ยฃ0.10 B-27.88%
2022 ยฃ0.14 B-30.39%
2021 ยฃ0.20 B50.12%
2020 ยฃ0.13 B49.1%
2019 ยฃ91.72 M-53.7%
2018 ยฃ0.19 B89.74%
2017 ยฃ0.10 B18.21%
2016 ยฃ88.31 M81.99%
2015 ยฃ48.52 M17.07%
2014 ยฃ41.45 M39.62%
2013 ยฃ29.68 M52.88%
2012 ยฃ19.41 M0.49%
2011 ยฃ19.32 M26.74%
2010 ยฃ15.24 M-36.64%
2009 ยฃ24.06 M29.12%
2008 ยฃ18.63 M187.15%
2007 ยฃ6.49 M-83.01%
2006 ยฃ38.19 M-59.8%
2005 ยฃ95.01 M15.04%
2004 ยฃ82.59 M4.68%
2003 ยฃ78.9 M30.91%
2002 ยฃ60.27 M14.47%
2001 ยฃ52.65 M61.11%
2000 ยฃ32.68 M29.22%
1999 ยฃ25.29 M137.59%
1998 ยฃ10.64 M-66.18%
1997 ยฃ31.47 M45.65%
1996 ยฃ21.6 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ25.89 B 24,274.05%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ20.48 M-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ32.04 B 30,056.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ49.73 B 46,708.46%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ44.29 B 41,586.27%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ32.53 B 30,514.26%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ37.76 B 35,437.69%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ11.93 B 11,135.56%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ69.81 B 65,600.71%๐Ÿ‡บ๐Ÿ‡ธ USA